News

1st Cushing’s patient dosed in ST-002 Phase 2 clinical trial

The first participant has been dosed in a Phase 2 clinical trial testing ST-002 in people with Cushing’s syndrome and high blood sugar levels. “ST-002 has the potential to change the treatment landscape for patients who currently have limited therapeutic options,” Manohar Katakam, PhD, CEO of treatment developer Sterotherapeutics,…

New imaging technique found to accurately ID pituitary tumors

An imaging technique developed by scientists in India may help clinicians accurately identify tumors associated with Cushing’s disease, including in cases that are difficult to diagnose with other methods, a study reports. This new method uses a novel form of positron emission tomography (PET) imaging alongside CT scans to…